Skip to main content
INMB
NASDAQ Life Sciences

INmune Bio's CORDStrom™ Platform Patent Advances in US, Securing Potential Protection Until 2045

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.61
Mkt Cap
$43.334M
52W Low
$1.09
52W High
$3.244
52W Position info
48% above low
Off High info
50% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

INMB sits 48% above its 52-week low of $1.09.

Summary

INmune Bio has advanced its CORDStrom™ platform patent application into the U.S. national phase, a critical step following a favorable international written opinion on its patentability. This development builds on recent positive UK regulatory feedback for the CORDStrom™ drug. If granted, this foundational patent family is projected to provide exclusive commercial protection for the platform and its lead drug Ebstrocel until at least 2045. This significantly de-risks a core asset and enhances the long-term valuation and commercial runway for the small-cap biotech.

At the time of this announcement, INMB was trading at $1.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $43.3M. The 52-week trading range was $1.09 to $3.24. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

INMB - Latest Insights

INMB
Nov 05, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.18
Real-time Price: $0.980 info
Change: -$0.195 (-17%) info
Market Cap: $30.044M info
INMB
Oct 29, 2026, 7:30 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.52
Real-time Price: $0.980 info
Change: -$0.540 (-36%) info
Market Cap: $30.044M info
INMB
Oct 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.41
Real-time Price: $0.980 info
Change: -$0.430 (-30%) info
Market Cap: $30.044M info
INMB
Oct 21, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.69
Real-time Price: $0.980 info
Change: -$0.709 (-42%) info
Market Cap: $30.044M info
INMB
Oct 21, 2026, 7:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $0.980 info
Change: -$0.650 (-40%) info
Market Cap: $30.044M info